# American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call Canonical URL: https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-third-quarter-2024-earnings-conferen-9e256779 Ticker: AMS Company: American Shared Hospital Services Source: American Shared Hospital Services Published: 2024-11-06 12:00 EST ## Summary American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call... ## Article Body American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its third quarter 2024 financial results on November 13 th at 1:00 pm ET / 10:00 am PT. The third quarter 2024 financial results press release will be issued before the market opens on November 13 th . Teleconference and Webcast Information To participate, domestic callers may dial 1-844-413-3972 and international callers may dial 1-412-317-5776 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call. A simultaneous webcast of the call may be accessed through the Company's website, www.ashs.com , or at www.streetevents.com for institutional investors. A replay of the call will be available at 1-877-344-7529 or 1-412-317-0088, access code 2069271, through November 20, 2024. The call will also be available for replay on the Company’s website at www.ashs.com . About American Shared Hospital Services (NYSE American: AMS) American Shared Hospital Services (ASHS) is a leading provider of creative financial and turnkey solutions to Cancer Treatment Centers, hospitals, and large cancer networks worldwide. The company works closely with all major global Original Equipment Manufacturers (OEMs) that provide leading edge clinical treatment systems and software to treat cancer using Radiation Therapy and Radiosurgery. The company is vendor agnostic and provides financial support for a wide range of products including MR Guided Radiation Therapy Linacs, Advanced Digital Linear Accelerators, Proton Beam Radiation Therapy Systems, Brachytherapy systems and suites, and through the Company’s subsidiary, GK Financing LLC., the Leksell Gamma Knife product and services. For more information, please visit: www.ashs.com Safe Harbor Statement This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services including statements regarding the expected continued growth of the Company and the expansion of the Company’s Gamma Knife, proton therapy and MR/LINAC business, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife and proton therapy businesses, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company’s Gamma Knife, proton therapy, and MR/LINAC businesses, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company’s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Quarterly Report on Form 10-Q for the three month period ended June 30, 2024, the Annual Report on Form 10-K for the year ended December 31, 2023, and the definitive Proxy Statement for the Annual Meeting of Shareholders that was held on June 25, 2024. Contacts: American Shared Hospital Services Ray Stachowiak, Executive Chairman and CEO rstachowiak@ashs.com Investor Relations Kirin Smith, President PCG Advisory, Inc. ksmith@pcgadvisory.com ## Recent Company News - 2026-05-22 11:00 EST — [American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-annual-shareholder-meeting-to-be-hel-653bf181) — Source: American Shared Hospital Services - 2026-05-14 11:00 EST — [American Shared Hospital Services Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-reports-first-quarter-2026-financial-results-ac741558) — Source: American Shared Hospital Services - 2026-05-12 11:00 EST — [American Shared Hospital Services Announces First Quarter 2026 Financial Results Conference Call](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-first-quarter-2026-financial-results-bc86f115) — Source: American Shared Hospital Services - 2026-03-31 11:00 EST — [American Shared Hospital Services Reports Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-reports-fourth-quarter-and-full-year-2025-fina-403f36a2) — Source: American Shared Hospital Services - 2026-03-24 11:00 EST — [American Shared Hospital Services Announces Fourth Quarter and Full Year Financial Results Conference Call](https://biopharmsignal.com/news/AMS/american-shared-hospital-services-announces-fourth-quarter-and-full-year-financi-50561737) — Source: American Shared Hospital Services ## Related News - 2026-07-29 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-second-quarter-fiscal--2a2c0c5a) - 2026-07-29 20:05 EST — VKTX — [Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/VKTX/viking-therapeutics-reports-second-quarter-2026-financial-results-and-provides-c-2f09b8ce) - 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9) - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)